Propanc Biopharma, Inc.(PPCB)
Biotechnology
Oncology Biotech
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership changeShares owned | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2015-01-13 | Nathanielsz James Andrew Chief Executive Officer | Sale | -330,500 | -3.29%9,701,761 | $0.18 | $60,083 | View SEC filing | |
| 2012-08-24 | Nathanielsz James Andrew Chief Executive Officer | Purchase | -250,000 | -2.49%9,782,261 | $0.20 | $50,000 | View SEC filing |
1-2 of 2